{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:36:14Z","timestamp":1760189774111,"version":"3.37.3"},"reference-count":18,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,3,23]]},"DOI":"10.1182\/bloodadvances.2020003980","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T15:55:17Z","timestamp":1616082917000},"page":"1733-1736","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":6,"title":["Clonal evolution and heterogeneity in advanced systemic mastocytosis revealed by single-cell DNA sequencing"],"prefix":"10.1182","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2282-0416","authenticated-orcid":false,"given":"Ken-Hong","family":"Lim","sequence":"first","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan;"},{"name":"Department of Medicine, MacKay Medical College, New Taipei City, Taiwan;"},{"name":"Good Clinical Research Center, Department of Medical Research, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo-Ning","family":"Wu","sequence":"additional","affiliation":[{"name":"Good Clinical Research Center, Department of Medical Research, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"To-Yu","family":"Huang","sequence":"additional","affiliation":[{"name":"Good Clinical Research Center, Department of Medical Research, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie-Yang","family":"Jhuang","sequence":"additional","affiliation":[{"name":"Department of Pathology, MacKay Memorial Hospital, Taipei, Taiwan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Cheng","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan;"},{"name":"Department of Medicine, MacKay Medical College, New Taipei City, Taiwan;"},{"name":"Good Clinical Research Center, Department of Medical Research, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan-Chau","family":"Lin","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan;"},{"name":"Good Clinical Research Center, Department of Medical Research, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Hao","family":"Chiang","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan;"},{"name":"Good Clinical Research Center, Department of Medical Research, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Wen","family":"Su","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan;"},{"name":"Department of Medicine, MacKay Medical College, New Taipei City, Taiwan;"},{"name":"Good Clinical Research Center, Department of Medical Research, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caleb Gon-Shen","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan;"},{"name":"Department of Medicine, MacKay Medical College, New Taipei City, Taiwan;"},{"name":"Good Clinical Research Center, Department of Medical Research, and"},{"name":"Department of Nursing, MacKay Junior College of Medicine, Nursing, and Management, New Taipei City, Taiwan; and"},{"name":"Institute of Molecular Medicine, National Tsing-Hua University, Hsin-Chu, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Fang","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan;"},{"name":"Department of Medicine, MacKay Medical College, New Taipei City, Taiwan;"},{"name":"Good Clinical Research Center, Department of Medical Research, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johnson","family":"Lin","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2021,3,18]]},"reference":[{"issue":"16","key":"2021031815353652400_B1","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood.2019000932","article-title":"New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosis","volume":"135","author":"Reiter","year":"2020","journal-title":"Blood"},{"issue":"3","key":"2021031815353652400_B2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ajh.25371","article-title":"Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management","volume":"94","author":"Pardanani","year":"2019","journal-title":"Am J Hematol"},{"issue":"20","key":"2021031815353652400_B3","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"23","key":"2021031815353652400_B4","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1182\/blood-2009-02-205237","article-title":"Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors","volume":"113","author":"Lim","year":"2009","journal-title":"Blood"},{"issue":"6","key":"2021031815353652400_B5","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3324\/haematol.2017.163964","article-title":"The clinical and molecular diversity of mast cell leukemia with or without associated hematologic neoplasm","volume":"102","author":"Jawhar","year":"2017","journal-title":"Haematologica"},{"issue":"18","key":"2021031815353652400_B6","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1182\/blood-2009-05-220145","article-title":"Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies","volume":"114","author":"Pardanani","year":"2009","journal-title":"Blood"},{"issue":"5","key":"2021031815353652400_B7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/ajh.23672","article-title":"Sensitive KIT D816V mutation analysis of blood as a diagnostic test in mastocytosis","volume":"89","author":"Kristensen","year":"2014","journal-title":"Am J Hematol"},{"issue":"14","key":"2021031815353652400_B8","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1182\/blood-2013-04-496448","article-title":"Comprehensive mutational profiling in advanced systemic mastocytosis","volume":"122","author":"Schwaab","year":"2013","journal-title":"Blood"},{"issue":"5","key":"2021031815353652400_B9","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/leu.2015.4","article-title":"Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event","volume":"29","author":"Jawhar","year":"2015","journal-title":"Leukemia"},{"issue":"1","key":"2021031815353652400_B10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/leu.2015.284","article-title":"Additional mutations in SRSF2, ASXL1 and\/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis","volume":"30","author":"Jawhar","year":"2016","journal-title":"Leukemia"},{"issue":"21","key":"2021031815353652400_B11","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1182\/bloodadvances.2018026245","article-title":"Mayo alliance prognostic system for mastocytosis: clinical and hybrid clinical-molecular models","volume":"2","author":"Pardanani","year":"2018","journal-title":"Blood Adv"},{"issue":"31","key":"2021031815353652400_B12","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1200\/JCO.19.00640","article-title":"MARS: Mutation-Adjusted Risk Score for advanced systemic mastocytosis","volume":"37","author":"Jawhar","year":"2019","journal-title":"J Clin Oncol"},{"issue":"26","key":"2021031815353652400_B13","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1056\/NEJMoa1513098","article-title":"Efficacy and safety of midostaurin in advanced systemic mastocytosis","volume":"374","author":"Gotlib","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"2021031815353652400_B14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1182\/blood-2017-01-764423","article-title":"Response and progression on midostaurin in advanced systemic mastocytosis: KIT D816V and other molecular markers","volume":"130","author":"Jawhar","year":"2017","journal-title":"Blood"},{"issue":"9","key":"2021031815353652400_B15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/2040620717721459","article-title":"Midostaurin: a novel therapeutic agent for patients with FLT3-mutated acute myeloid leukemia and systemic mastocytosis","volume":"8","author":"Gallogly","year":"2017","journal-title":"Ther Adv Hematol"},{"issue":"2","key":"2021031815353652400_B16","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/leu.2017.234","article-title":"Efficacy and safety of midostaurin in patients with advanced systemic mastocytosis: 10-year median follow-up of a phase II trial","volume":"32","author":"DeAngelo","year":"2018","journal-title":"Leukemia"},{"issue":"6","key":"2021031815353652400_B17","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/nm.4097","article-title":"Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins","volume":"22","author":"Lee","year":"2016","journal-title":"Nat Med"},{"issue":"1","key":"2021031815353652400_B18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40364-018-0142-y","article-title":"SRSF2 mutations in myelodysplasia\/myeloproliferative neoplasms","volume":"6","author":"Aujla","year":"2018","journal-title":"Biomark Res"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/6\/1733\/1803025\/advancesadv2020003980.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/6\/1733\/1803025\/advancesadv2020003980.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T11:12:35Z","timestamp":1698059555000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/5\/6\/1733\/475525\/Clonal-evolution-and-heterogeneity-in-advanced"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,18]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,3,23]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2020003980","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"type":"print","value":"2473-9529"},{"type":"electronic","value":"2473-9537"}],"subject":[],"published":{"date-parts":[[2021,3,18]]}}}